首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR INJECTIONS HAVING NEUROPROTECTOR, ANTIAMNESIC, ANTIOXIDANT, ANTIHYPOXIC AND ANTIISCHAEMIC ACTIVITY (EMBODIMENTS)

PHARMACEUTICAL COMPOSITION FOR INJECTIONS HAVING NEUROPROTECTOR, ANTIAMNESIC, ANTIOXIDANT, ANTIHYPOXIC AND ANTIISCHAEMIC ACTIVITY (EMBODIMENTS)

机译:具有神经保护剂,抗记忆药,抗氧化剂,抗缺氧和抗精神分裂症活性的注射剂的药物成分(元素)

摘要

The invention relates to the field of the pharmaceutical industry and medicine. The problem of the invention consists in producing an effective pharmaceutical composition having neuroprotector, antiamnesic, antioxidant, antihypoxic and antiischaemic activity. The problem is solved in that the pharmaceutical composition for injections comprises 2-ethyl-6-methyl-3-hydroxypyridine succinate, and differs from the prototype by that it additionally comprises the following mineral substances: potassium, magnesium, iron, manganese. Moreover, in the pharmaceutical composition, some of theC carbon isotopes are substituted byC carbon isotopes. The technical results of the invention consist in increasing the rate at which a therapeutic effect is achieved, increasing the therapeutic effect without increasing the concentration of the preparation 2-ethyl-6-methyl-3-hydroxypyridine succinate, and increasing the stability over the shelf life.
机译:本发明涉及制药工业和医药领域。本发明的问题在于生产具有神经保护剂,抗记忆,抗氧化剂,抗缺氧和抗局部缺血活性的有效药物组合物。解决了该问题,因为用于注射的药物组合物包含2-乙基-6-甲基-3-羟基吡啶基琥珀酸酯,并且与原型的不同之处在于其另外包含以下矿物质:钾,镁,铁,锰。此外,在药物组合物中,一些C碳同位素被C碳同位素取代。本发明的技术结果在于提高获得治疗效果的速率,在不增加制剂2-乙基-6-甲基-3-羟基吡啶基琥珀酸酯的浓度的情况下提高治疗效果,以及提高在货架上的稳定性。生活。

著录项

  • 公开/公告号EA022859B1

    专利类型

  • 公开/公告日2016-03-31

    原文格式PDF

  • 申请/专利权人 N.C.PHARM LTD.;

    申请/专利号EA20120000234

  • 申请日2012-03-02

  • 分类号A61K31/4412;A61K9/08;A61K9/14;A61K33;A61K33/06;A61K33/30;A61K47/02;A61P25;A61P39/06;

  • 国家 EA

  • 入库时间 2022-08-21 14:26:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号